(Q35201353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Treatment of in-transit melanoma with intra-lesional interleukin-2: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Brett A Byers

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Claire F Temple-Oberle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

J Greg McKinnon

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

3 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

Journal of Surgical Oncology

21 March 2020

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

770-775

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

Final version of 2009 AJCC melanoma staging and classification

21 March 2020

cites work

1 reference

Ten-year survival with multiple metastatic malignant melanoma. Primary site unknown.

21 January 2018

1 reference

Treatment of metastatic malignant melanoma

21 January 2018

1 reference

A review of recent findings involving interleukin-2-based cancer therapy

21 January 2018

1 reference

Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma

21 January 2018

1 reference

Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream

21 January 2018

1 reference

Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases

21 January 2018

1 reference

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma

21 January 2018

1 reference

Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels

21 January 2018

1 reference

Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma

21 January 2018

1 reference

Intralesional granulocyte-monocyte colony-stimulating factor followed by subcutaneous interleukin-2 in metastatic melanoma: a pilot study in elderly patients

21 January 2018

1 reference

Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.

21 January 2018

1 reference

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

21 January 2018

1 reference

Reporting results of cancer treatment

21 January 2018

1 reference

Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria

21 January 2018

1 reference

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

21 January 2018

1 reference

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

21 January 2018

1 reference

Topical imiquimod in the treatment of metastatic melanoma to skin

21 January 2018

1 reference

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group

21 January 2018

1 reference

Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group

21 January 2018

1 reference

High response rate after intratumoral treatment with interleukin-2

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24996052%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference